Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PT Phapros Tbk's share price for the quarter that ended in Mar. 2026 was Rp260. PT Phapros Tbk's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 840 Mil. Therefore, PT Phapros Tbk's market cap for the quarter that ended in Mar. 2026 was Rp218,400 Mil.
PT Phapros Tbk's quarterly market cap
declined
from Sep. 2025 (Rp273,840 Mil) to Dec. 2025 (Rp252,000 Mil) and
declined
from Dec. 2025 (Rp252,000 Mil) to Mar. 2026 (Rp218,400 Mil).
PT Phapros Tbk's annual market cap
declined
from Dec. 2023 (Rp537,600 Mil) to Dec. 2024 (Rp272,160 Mil) and
declined
from Dec. 2024 (Rp272,160 Mil) to Dec. 2025 (Rp252,000 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Phapros Tbk's Enterprise Value for Today is Rp786,025 Mil.
PT Phapros Tbk (ISX:PEHA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Phapros Tbk Market Cap Related Terms
PT Phapros Tbk Market Cap Historical Data
* Premium members only.
The historical data trend for PT Phapros Tbk's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PEHA vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Phapros Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Phapros Tbk Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Phapros Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Phapros Tbk's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PT Phapros Tbk's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Phapros Tbk (ISX:PEHA) has a Market Cap of Rp188,160 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Phapros Tbk and its competitors. According to the industry distribution chart, PT Phapros Tbk ranks #870 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 85%.
Is PT Phapros Tbk's Market Cap too high?
PT Phapros Tbk's current Market Cap is Rp188,160 Mil. Based on the distribution chart, PT Phapros Tbk ranks #870 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PT Phapros Tbk has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Phapros Tbk's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Phapros Tbk ranks #870 out of 1024 companies for Market Cap. This places PT Phapros Tbk in the lower half of its industry. The industry median Market Cap is 217.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 217.83, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Phapros Tbk and its competitors. For the Drug Manufacturers industry, the median Market Cap is 217.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Phapros Tbk's current Market Cap is Rp188,160 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Phapros Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Phapros Tbk (ISX:PEHA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp385.17, compared to a current price of Rp224.00 — trading 41.8% below its estimated fair value. The current Market Cap is Rp188,160 Mil. PT Phapros Tbk's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Phapros Tbk (ISX:PEHA), the current Market Cap is Rp188,160 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued.
The current stock price of Rp224.00 is trading 41.8% below its estimated GF Value™ of Rp385.17.
GuruFocus considers PT Phapros Tbk to be Possible Value Trap.
Key valuation signals for ISX:PEHA:
Market Cap: Rp188,160 Mil
GF Value™: Rp385.17 vs. price of Rp224.00 (41.8% below fair value)
No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
69GF Score
Get the complete analysis for ISX:PEHA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PEHA has been successfully added to your 
